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Background: Cardiac resynchronization therapy (CRT) is an established
therapy for patients with advanced heart failure and wide QRS complex. How-
ever, a large number of patients do not respond to CRT.
Aims: To assess the value of real-time three-dimensional echocardio-
graphy (RT3DE) to predict response to CRT.
Methods: Patients with standard CRT indications were enrolled. Patients
with three-dimensional asynchrony (systolic dyssynchrony index (SDI) >8%)
have a potentially good response to CRT and they underwent activated resyn-
chronization therapy (CRT ON). For other patients (SDI<8%), the response to
CRT is much more uncertain and they were randomly assigned to an activated
resynchronization group (CRT ON) or to a non activated resynchronization
group (CRT OFF). Clinical and echocardiographic assessments were per-
formed at baseline and 3 and 6 months after device implantation.
Results: Eighteen patients were enrolled and followed for 6 months. Three
patients were excluded from the statistical analysis because of incomplete
data. All patients in CRT ON (n=11) had improved exercise tolerance (New
York Heart Association (NYHA) functional class: –1.55 vs –0.5 (p=0.045),
peak VO2: +35 vs +14%), quality of life (+71 vs +27%) and left ventricular
function (+46 vs 0%). Patients with three-dimensional asynchrony (SDI>8%)
had greater improvement after CRT than patients with SDI<8% (NYHA: –1.6
vs –1.5, quality of life: +85 vs 58%, left ventricular ejection fraction: +67 vs
15%). 
Conclusion: Cardiac resynchronization results in significant clinical and
echocardiographic improvement in patients who have severe heart failure and
intraventricular delay. In addition, RT3DE seems to be highly predictive for
acute response to CRT.
